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These experiments identify an Epstein-Barr virus-encoded gene product, called ZEBRA (BamHI fragment Z
Epstein-Barr replication activator) protein, which activates a switch between the latent and replicative life cycle
of the virus. Our previous work had shown that the 2.7-kilobase-pair WZhet piece of rearranged Epstein-Barr
virus DNA from a defective virus activated replication when introduced into cells with a latent genome, but it
was not clear whether a protein product was required for the phenomenon. We now use deletional,
site-directed, and chimeric mutagenesis, together with gene transfer, to show that a 43-kilodalton protein,
encoded in the BZLF1 open reading frame of het DNA, is responsible for this process. The rearrangement in
defective DNA does not contribute to the structural gene for the protein. Similar proteins with variable
electrophoretic mobility (37 to 39 kilodaltons) were encoded by BamHI Z fragments from standard,
nondefective Epstein-Barr virus genomes. Plasmids expressing the ZEBRA proteins from B95-8 and HR-1
viruses were less efficient at activating replication in D98/HR-1 cells than those which contained the ZEBRA
gene from the defective virus. It is not yet known whether these functional differences are due to variations in
expression of the plasmids or to intrinsic differences in the activity of these polymorphic polypeptides.
The life cycle of the Epstein-Barr herpesvirus (EBV) in
immortalized human B lymphocytes is divided into two
phases called latency and replication. During latency the
viral genome is circular and largely extrachromosomal. Only
certain viral genes are expressed in latency: those encoding
two small RNAs (EBERs), a family of at least four nuclear
products (EBNAs), and a latent membrane protein (6, 11-13,
19, 25, 29). Latent EBV genomes replicate coordinately with
the cell genome and are equally partitioned to daughter cells.
The viral genome contains an origin of plasmid maintenance
(oriP), which is thought to play a role in genome partitioning
(34). During the phase of viral replication a large number
(more than 50) of new mature viral transcripts and as many
viral polypeptides appear (14). These are conventionally
classified as early antigens (preceding viral DNA replication)
and late antigens, including capsid and envelope antigens.
Linear viral DNA is encapsidated into viral particles.
The switch between latency and replication can be acti-
vated by diverse stimuli including phorbol ester tumor
promoters, sodium butyrate, anti-immunoglobulin, and a
factor in serum (2, 18, 35). The pathway by which these
signals activate viral replication is unknown.
A class of defective EBV virions is also able to disrupt
latency and activate replication of latent EBV (22). These
defective virions contain an extensively deleted and rear-
ranged EBV genome, called heterogeneous (het) DNA. To
identify the viral genes on het DNA which are responsible
for disrupting latency, cloned het DNA fragments have been
introduced into cells with a latent EBV genome. One DNA
clone, termed BamtiHI WZhet or BamnHI het 2.7, is capable of
activating the expression of many viral replicative polypep-
tides within 24 h after transfection into a monolayer somatic
cell hybrid line, D98/HR-1, with a latent genome (5). Up to
1% of transfected D98/HR-1 cells express replicative anti-
gens, whereas less than 0.01%, of the cells spontaneously
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synthesize these products. The same DNA clone, when
stably transferred into the X50-7 lymphoblastoid cell line,
under drug selection also markedly enhanced expression of
the viral replicative cycle (10). Some clones of X50-7 cells
which have received and express WZhet make viral replica-
tive products in 10% of the cells, whereas less than 0.01% of
parental X50-7 cells express replicative products. Further-
more X50-7 cells containing WZhet release infectious virus.
Thus WZhet is competent to drive the EBV replicative cycle
to completion with the synthesis of mature virions.
The active 2,700-base-pair (bp) WZhet fragment is exten-
sively rearranged. It represents a fusion and inversion of two
portions of EBV DNA which are separated by more than 50
kbp on the standard EBV genome. This rearranged DNA
fragment contains only one complete open reading frame.
Transfers of DNA which have been resected in this open
reading frame do not activate viral replication in D98/HR-1
cells (5). Such experiments favor the idea that WZhet does
not act by some property of the DNA itself, for example, by
binding a repressor, but instead must make a product.
However this point has not been proved by experiment.
The purpose of the present experiments was to define the
product responsible for disruption of latency. We wished to
compare the product made by standard and defective virus
and to learn whether the rearrangement of DNA in WZhet
contributed to coding sequences of the product.
(This work was presented in preliminary form at the 11th
annual Herpesvirus Workshop, Leeds, England, August
1986.)
MATERIALS AND METHODS
Viral DNA fragments. Identification and cloning of the
rearranged 2.7-kbp WZhet fragment was as described previ-
ously (5). The standard BamnHl Z fragments of viral DNA
from EBV strains B95-8, FF41, and P3J-HR-1 were cloned
into pSV2neo by using conventional techniques (28). WZhet
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and standard BamHI-Z from the HR-1 strain were se-
quenced by the dideoxy chain-termination method (26).
Mutant plasmids. Deletion mutants which invaded WZhet
DNA from the 5' end were constructed by the Bal 31
exonuclease technique as described previously (24). WZhet
in pBR322 was linearized with EcoRI and digested for
various lengths of time with Bal 31, and BamHI linkers were
ligated onto the ends. The constructs were digested with
BamHI and ligated into pSV2neo. The sizes of the deletions
were determined by electrophoresis on polyacrylamide gels
after digestion with SmaI and a variety of other restriction
endonucleases.
Two site-specific mutants were generated at the HindIlI
and NheI sites in BZLF1. The HindIll site was removed by
filling in the 3' recessed ends left by HindlIl digestion by
using the Klenow fragment of DNA polymerase I and
deoxynucleotides, followed by religation. The NheI site was
eliminated by removing the 5' overhang with mung bean
nuclease followed by religation. WZhet fragments containing
these mutations had lost the respective restriction endonu-
clease recognition site but were not otherwise altered in
electrophoretic mobility.
A chimeric plasmid pSV2neo-WZhet-psi 1 was con-
structed to contain 5' sequences of WZhet (BamHI to
HindIll) and 3' sequences from standard (HR-1) BamHI-Z
(HindIll to BamHI). The 1.7-kbp BamHI-HindlIl subfrag-
ment of WZhet was subcloned from pSVod into pSV2neo.
This plasmid is designated pCJ1.7. A HindIII fragment
encompassing the carboxy end of standard HR-1 BZLF1 and
adjacent sequences of pSV2neo was then cloned into
pCJ1.7.
A second chimeric plasmid, pSV2neo-WZhet-psi 2, was
constructed to contain 5' sequences of standard (HR-1)
BamHI-Z (BamHI to the second HindIII site) and 3' se-
quences from WZhet (HindIII to BamHI). pSV2neo-Z
(HR-1) was cleaved completely with EcoRI and only par-
tially with HindIlI (partial digestion was monitored by
agarose gel electrophoresis). When partial digestion was
optimized, pSVOd-1.0 (5), which had also been digested
with EcoRI and HindIII was added, and the mixture was
ligated. After identification of DNA clones containing the
proper insert, the insert was recloned into the BamHI site of
pSV2neo (see Fig. 8A).
To construct pSV2neo-BZLF1, mutant 81 was digested
with BamHI and Ncol. The NcoI site is at the first base of
the BZLF2 open reading frame. The ends were flushed by
using the Klenow fragment of DNA polymerase I and
nucleoside triphosphates. The 1,556-bp fragment containing
the BZLF1 open reading frame and surrounding sequence
was excised from a 5% polyacrylamide gel. This fragment
was ligated into pSV2neo which had been cut at the BamHI
site, whose ends were flushed as above and treated with calf
intestine phosphatase (Boehringer Mannheim Biochemi-
cals).
Cells. D98/HR-1 cells, a gift from R. Glaser (Ohio State
University), are hybrids between adenine phosphoribosyl-
transferase-negative D98 cells and the P3J-HR-1 Burkitt
lymphoma line (7). These cells have a very low rate of
spontaneous expression of the EBV replicative cycle (<1 in
106 cells produce viral replicative antigens) but do express
EBNA 1 in every cell. They were maintained in minimal
essential medium containing 10% fetal bovine serum and
MAGGT (0.6 ,uM methotrexate, 50 ,uM adenosine, 50 ,uM
guanosine, 0.1 mM glycine, 16 ,uM thymidine) (23).
D98/HR-1 cells were maintained by weekly splits at a 20:1
cell ratio and by a 5:1 split when used for transfection.
COS-1 cells were used to examine chimeric plasmids for
expression of proteins (8). The cells were grown in Dulbecco
modified minimal essential medium with 5% fetal bovine
serum. They were maintained by weekly 20:1 cell splits and
seeded at 5:1 cell splits into 100-mm petri dishes before
transfection.
Transfection. D98/HR-1 cells and COS-1 cells were seeded
into 100-mm petri dishes 3 days before transfection.
D98/HR-1 cells were transfected with 8 ,ug of cloned DNA
by the calcium method (9). Transfers of 10 ,ug of DNA into
COS-1 cells was by the DEAE-dextran method followed by
treatment with chloroquine (21).
Immunoblots. At 48 to 72 h after transfection, cells from a
100-mm dish were scraped into 0.5 ml of sodium dodecyl
sulfate sample buffer. Extracts were sonicated for 15 s and
boiled for 5 min. Approximately one third of each total
extract was electrophoresed on a sodium dodecyl sulfate-
10% polyacrylamide gel and transferred to a nitrocellulose
filter (31). A skim milk solution (Blotto) was used to block
the filter before incubation with antibody (17).
Antisera. Polyclonal human antiserum SC with high titers
to EBV replicative proteins, including ZEBRA, came from a
patient with putative chronic EBV infection. The serum was
the gift of J. Jones, Denver, Colorado. A human antiserum,
RM, from a healthy individual convalescent from mononu-
cleosis was used to identify the latent EBV nuclear antigens
(25). A monospecific antiserum (Alexander) was prepared in
a rabbit to a fusion protein between P-galactosidase and the
last 330 nucleotides of BZLF1 (27).
RESULTS
Structure of the WZhet fragment (Fig. 1). On the basis of
nucleotide sequence, the rearranged EBV DNA fragment
which activates the switch from the latent to the replicative
life cycle of the virus is 2,711 bp in length. (H. Jenson and G.
Miller, submitted for publication). It contains 1,134 bp from
BamHI-W, the first large internal repeat in the genome, and
1,577 bp from BamHI-Z, a region which is more than 50 kbp
away in the standard EBV genome. WZhet DNA contains
only a single complete open reading frame (BZLF1 in the
Cambridge terminology), whose orientation in the rear-
ranged het DNA is opposite to that in the standard EBV
genome (1). Portions of three other open reading frames are
represented in the active WZhet fragment; these are desig-
nated BWRF1 (in the BamHI-W region) and BRLF1 and
BZLF2 (in the BamHI-Z portion). The junction between
sequences derived from BamHI-W and those from BamHI-Z
is at the first T in the sequence TATAAA which is thought to
function as a TATA box for latent mRNAs (15). Thus this
TATA box is removed. Furthermore two exons of a multiply
spliced latent nuclear protein encoded within BamHI-W are
not found in WZhet (3).
One underlying purpose of our experiments was to learn
whether this rearrangement ofDNA affected the structure of
a product responsible for activating EBV replication, for
example, by fusing exons which were not contiguous on the
genome. Accordingly we examined a series of deletion
mutants which removed progressively more of the se-
quences from BamHI-W. The location of these deletions is
shown in Fig. 1B.
Identification of the products from WZhet and from stan-
dard BamHI Z fragments (Fig. 2). To identify protein prod-
ucts encoded by the rearranged WZhet fragment and by the
components of standard EBV DNA from which WZhet was
derived, BamHI WZhet, BamHI-W, and BamHI-Z from
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FIG. 1. (A) Diagram of the structure of the BamHI WZhet fragment, based on its nucleotide sequence (Jenson and Miller, submitted).
Letters such as BWRF1 and BZLF1 refer to open reading frames in the Cambridge terminology, e.g., BZLF1 is BamHI-Z leftward frame one
(1). Numbers in parentheses (n) are base pairs from each reading frame remaining in WZhet. (B) The location and extent of deletions and
site-directed mutations used in this study.
several EBV strains were cloned in pSV2neo and introduced
into COS-1 cells. A single prominent protein detected by
immunoblotting was expressed from WZhet and the stan-
dard BamHI Z fragment from three EBV strains. No protein
was detected after transfer of pSV2neo-BamHI-W into
COS-1 cells (data not shown). This result suggested that the
protein made by WZhet was likely to be encoded by se-
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FIG. 2. Electrophoretic mobility of ZEBRA proteins. Shown is
an immunoblot of proteins extracted from COS-1 cells transfected
with various pSV2neo plasmids containing WZhet, standard
BamHI-Z from strains HR-1, FF41, and B95-8, WZhet with the
HindilI site filled in (WZhet-HR), and the chimeric plasmid (WZhet-
psi 1). The immunoblot was reacted with a 1:250 dilution of a
polyvalent human antiserum, SC. Note the variation in electropho-
retic mobility of the ZEBRA proteins.
quences derived from BamHI-Z. However, reproducible
differences in electrophoretic mobility among these proteins
were observed. WZhet caused the expression of a protein of
about 43 kilodaltons (kDa). The protein from the BamHI-Z
DNA fragment of EBV strain HR-1 (from which WZhet is
derived) migrated at about 39 kDa, and those expressed from
comparable DNA fragments of two immortalizing viruses,
B95-8 and FF41, ran at about 37 kDa. A chimeric plasmid,
WZhet-psi 1, which contained the leftmost BamHI-HindIII
subfragment (and thus the amino terminus of BZLF1) of
WZhet and the leftmost BamHI-HindIII subfragment (and
corresponding carboxy end of BZLF1) of standard (HR-1)
BamHI-Z (see Fig. 1 and Fig. 8) was constructed. WZhet-psi
1 produced a protein with electrophoretic mobility identical
to that of the protein encoded by WZhet. The ZEBRA
protein encoded by the second chimeric plasmid WZhet-psi
2 (see Fig. 8), which contained the amino terminus of
standard HR-1 BZLF1 and the carboxy terminus of het
BZLF1, migrated at about 42 kDa (data not shown; J.
Countryman, Ph.D. Thesis, Yale University, New Haven,
Conn., 1987).
The product from WZhet and standard BamHI-Z is encoded
by BZLF1. We obtained four types of direct evidence which
proved that the 43-kDa protein expressed by WZhet was
encoded by BZLF1. Restriction endonuclease site-directed
frameshift mutations were produced in BZLFl-one at the
HindIII site (260 bp into the open reading frame) and another
at the NheI site (420 bp into BZLF1). Neither of these
mutations, both of which would be expected to put the
coding region out of frame, was able to express protein in
COS-1 cells (Fig. 2, lane 5; data not shown).
We examined deletion mutants which removed progres-
sively more DNA from the BamHI-W region of the WZhet
fragment for their capacity to express the product in COS-1
cells (Fig. 3). A mutant such as number 81, which removed
B -
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all but 147 bp of BamHI-W, still expressed a 43-kDa protein
in COS-1 cells. Mutant number 80, which removed all of the
BamHI W sequences as well as 73 bp from BRLF1, also
expressed a 43-kDa protein, although in several trials less of
the protein appeared to be made in COS-1 cells. These
experiments showed that the differences in electrophoretic
mobility between the 43-kDa WZhet protein and the 39-kDa
standard Z (HR-1) protein were not due to fusion of exons
which were derived from BamHI-W. A deletion mutant
(number 28 in Fig. 3) which invaded BZLF1 did not make
any proteins in COS-1 cells detectable by immunoblotting.
A plasmid which entirely eliminated the BZLF2 reading
frame from mutant 81 by resection at the NcoI site also
encoded the 43-kDa protein (data not shown; Countryman,
Ph.D. thesis). Together these mutants narrowed the coding
region for the 43-kDa ZEBRA protein to 1,335 bp within
BamHI-Z, which contains only the BZLF1 open reading
frame.
Antibodies raised in a rabbit to the carboxy end of BZLF1
expressed in bacteria as a lac fusion protein, detected the
protein made in COS-1 cells (Fig. 4). This antibody detected
the same difference in electrophoretic mobility between
WZhet and the standard Z (HR-1) protein which was seen
with polyvalent antibodies.
These lines of evidence together indicate that the poly-
morphic protein seen after gene transfer into COS-1 cells is
encoded entirely in sequences derived from a 1.3-kbp
subfragment of BamHI-Z.
Disruption of latency by plasmids containing standard
BamHI-Z sequences. One assay for disruption of latency is to
measure on immunoblots the abundance of a number ofEBV
replicative polypeptides in D98/HR-1 cells which have been
transfected with different plasmids (Fig. 5). D98/HR-1 cells
usually have a low background of cells spontaneously in-
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FIG. 4. Detection ofZEBRA proteins with human antiserum and
a rabbit antiserum raised to a fusion protein containing the carboxy
end of BZLF1. pSV2neo plasmids containing WZhet or standard
BamHI-Z were transfected into COS-1 cells. Immunoblots of COS-1
cell extracts were reacted with a 1:250 human antiserum SC or with
a 1:50 dilution of the rabbit anti-BZLF1. Note that both antisera
detect the same difference in electrophoretic mobility of the
proteins.
duced into the viral replicative cycle (<1 in 106). This
background accounts for the EBV polypeptides seen in
D98/HR-1 cells which received pSV2neo. After induction of
replication by phorbol ester (phorbol 12-myristate 13-
acetate), there was an overall increase in both the abundance
and number of viral replicative polypeptides. Induction by
WZhet and the chimeric WZhet-psi 1 appeared, on inspec-
tion, to be slightly less efficient than induction by phorbol
12-myristate 13-acetate (Fig. 5). Standard BamHI-Z frag-
ments from three EBV strains, HR-1, FF41, and B95-8,
induced appearance of replicative polypeptides at a lower
level than WZhet or WZhet-psi 1. Densitometer tracings
of the autoradiograph at the position of two replicative
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FIG. 3. ZEBRA proteins made in COS-1 cells by WZhet and
deletion mutants which invade WZhet from the left end. Note that
mutant 80, which eliminates all of the sequences from BamHI-W,
still makes a ZEBRA protein with the electrophoretic mobility of
WZhet ZEBRA protein. Mutant 28, which invades BZLF1, makes
no protein.
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FIG. 5. Induction of expression of EBV replicative proteins after
treatment of D98/HR-1 cells with TPA or after transfection with
pSV2neo alone or containing WZhet, standard BamHI-Z from
strains HR-1, FF41, or B95-8, or the chimeric mutant WZhet-psi 1.
An immunoblot of D98/HR-1 cell extracts was reacted with a 1:250
dilution of human antiserum SC.
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polypeptides of 40 and 32 kDa confirmed the visual impres-
sions.
It is known that after induction of the EBV replicative
cycle there is no increase in the abundance of the latent
polypeptide EBNA 1 or its mRNA (32). This served as a
control to show that cell extracts in which we measured
changes in the abundance of replicative polypeptides (Fig. 5
and 6) contained equivalent amounts of total protein. When
an immunoblot containing identical amounts of cell extracts
(Fig. 5) was probed with an antiserum which contains
antibodies directed primarily to latent gene products, the
level of EBNA 1 polypeptide was the same in all lanes (data
not shown). Therefore the variations in induction of replica-
tive polypeptides seen in Fig. 5 and 6 were due to differences
in the plasmids introduced into the D98/HR-1 cells. This
series of experiments indicated that induction of expression
of EBV replicative proteins does not require the rearrange-
ment such as found in WZhet; however the WZhet fragment
is more efficient at the process of disrupting latency than
standard BamHI-Z.
Effects of deletional, site-directed, and chimeric mutations
on induction of D98/HR-1 cells. We compared induction by
pSV2neo plasmids containing WZhet, standard HR-1 Z, and
various deletional and frameshift mutations of WZhet (Fig. 6
and 7). Once again induction of D98/HR-1 cells by WZhet
was more efficient than induction by Z (HR-1). Deletions
which removed BamHI-W sequences from the WZhet frag-
ment were still able to induce replicative proteins. Mutant
28, which invaded BZLF1 and failed to express protein, was
unable to disrupt latency. Mutant 80, which removed all of
the BamHI-W sequences, and mutant 81, which left only 144
bp ofBamHI-W, both induced replication; however the level
of induction by these two mutants was somewhat lower than
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FIG. 6. Induction of expression of EBV replicative polypeptides
in D98/HR-1 cells by WZhet, standard HR-i BamHI-Z, WZhet with
the Hindlll fill-in (WZhet-HR) and various deletion mutants from
the left end. Note that neither WZhet-H nor mutant 28, both' of
which alter BZLF1, induces expression of EBV replicative
polypeptides.
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FIG. 7. Induction of replicative antigens by WZhet, two chi-
meric mutants, and BZLF1; immunoblot of replicative antigens
induced in D98/HR-1 cells after transfection with pSV2neo or
pSV2neo containing WZhet, the two chimeric mutants (WZhet-psi 1
and WZhet-psi 2), or the BZLF1 open reading frame (BZLF1-5).
The polyvalent human antiserum SC was used to detect replicative
antigens.
that brought about by other deletion mutants which retained
more BamHI-W sequences.
The two site-directed mutations at the HindlIl and NheI
sites in BZLF1, which destroyed the ability of the plasmids
to express protein in COS-1 cells (Fig. 3), also eliminated the
capacity of these plasmids to induce replicative polypeptides
(Fig. 6; data not shown). Thus induction of the EBV repli-
cative cycle required expression of the protein encoded by
BZLF1. The minimal current limits of the DNA encoding the
protein responsible for disruption of latency is about 1.3 kbp.
Mutants BZLF1-5 and 80 define this limit (Fig. 7, 8, and 9).
DISCUSSION
Evidence that ZEBRA protein is required for disruption of
latency. The purpose of our experiments was to ask whether
disruption of EBV latency by the 2.7-kbp WZhet DNA
fragment occurred by virtue of a protein product encoded by
this DNA. Preliminary data showed that, when cleaved at
the HindlIl site in BZLF1, plasmids containing WZhet were
no longer able to disrupt latency (5). But this cleavage could
have interrupted a protein-binding domain on the DNA or a
protein-coding domain; therefore the experiments were not
conclusive.
We have now obtained several lines of evidence which
indicate that the 43-kDa protein encoded by the BZLF1
reading frame in WZhet is responsible for the activation of
expression of replicative polypeptides. Deletional and site-
directed mutants in BZLF1 which are unable to express the
ZEBRA protein in CQS-1 cells (Fig. 2 and 3) are likewise
unable to induce expression of replicative proteins in
D98/HR-1 cells (Fig. 5, 6, and 7). Standard viruses without
defective genomes encode ZEBRA proteins which vary from
that encoded by WZhet both in electrophoretic mobility
(Fig. 2) and in their capacity to disrupt latency (Fig. 5 and 6).
Thus there appears to be a family of ZEBRA proteins which
vary in their electrophoretic mobility and in their biologic
J. VIROL.
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FIG. 8. Structure of WZhet and mutant DNA; comparison of WZhet DNA with standard HR-1 BamHI-Z, two deletion mutants (81 and
80), two chimeric mutants (WZhet-psi 1 and WZhet-psi 2), and BZLF1. For each DNA the electrophoretic mobility of ZEBRA in COS-1 cells
and the relative induction efficiency in D98/HR-1 cells is noted. Symbols and abbreviations: + + +, maximum induction efficiency; 0, the least
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BamHI-W sequence; -, WZhet sequence; , BamHI-Z sequence; X, location of amino acid differences which distinguish BZLF1
(WZhet) from BZLF1 (HR-1).
activity. This might account for differences among EBVs in
their tendency to enter the replicative life cycle spontane-
ously or in their capacity to disrupt latency when added to
cells with a latent genome.
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FIG. 9. Diagrammatic comparison of BZLF1 from standard
BamHI-Z, WZhet, and the chimeric mutants. BZLF1 (HR-1) con-
tains an additional 28 bp later followed by a 1-bp deletion, by
comparison to BZLF1 (B95-8). The relative locations of the five
amino acid changes which distinguish BZLF1 (HR-1) from BZLF1
(WZhet) are shown, as are their positions in the chimeric mutants.
In related experiments we have studied ZEBRA expres-
sion during constitutive expression of the viral replicative
life cycle in cell lines which spontaneously make virus and
after induction of replication by TPA or butyrate (N. Taylor,
J. Countryman, C. Rooney, D. Katz, and G. Miller, manu-
script in preparation). Using a potent antiserum to ZEBRA
we have detected ZEBRA expression whenever the viral
replicative cycle is activated. Thus ZEBRA expression does
not require defective virus, but is an invariant marker for
switch of the virus from latency to replication.
Differences in electrophoretic mobility of ZEBRA proteins.
According to DNA sequence data which will be presented in
detail elsewhere (Jenson and Miller, submitted), the BZLF1
from B95-8 virus (the prototype transforming strain which
was completely sequenced [1]) differs considerably from that
in HR-1 virus, the nonimmortalizing EBV strain which was
the source of the defective virus. The reading frame is 27 bp
longer in HR-1, and there is a frameshift which could result
in the translation of a protein which differs in its carboxy end
(Fig. 8 and 9; data not shown). In addition there are 27
scattered bp changes of which 15 result in an amino acid
change. This might explain the reproducible difference seen
in the electrophoretic mobility between ZEBRAs from B95-8
and HR-1 (Fig. 2 and 3).
However there is also a reproducible 4-kDa difference in
electrophoretic mobility between ZEBRA made from the
HR-1 defective virus and that made by the HR-1 standard
virus (Fig. 2, 3, and 4). Although this difference is only
illustrated in this report in COS-1 cells transfected with
pSV2neo-Z (HR-1) and pSV2neo-WZhet (Fig. 2 and 3), the
same difference in size is seen in HR-1 cells with and without
defective virus (Taylor et al., in preparation). We initially
thought that this difference in electrophoretic mobility might
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be the consequence of a contribution of BamHI-W DNA to
the coding sequences for the protein. However deletional
mutagenesis (Fig. 3) disproved this hypothesis. In comparing
sequences of BZLF1 between HR-1 and WZhet, there are
only five amino acid changes and no deletions or insertions
(Fig. 8; H. Jenson, manuscript in preparation). These amino
acid alterations may directly affect electrophoretic mobility,
or they may affect posttranslational modification of the
protein, if it occurs. Three of these five amino acid changes
are present in the chimeric WZhet-psi 1, which has the
electrophoretic mobility of WZhet.
The BZLF1 reading frame is 627 bp long in WZhet,
assuming that it is used in an unspliced form. This reading
frame would encode a protein of about 23 kDa, yet the
protein migrates at 43 kDa. We have shown that only 1.3 kbp
ofDNA is required to encode this 43-kDa protein and that no
other identified reading frames besides the 627-bp BZLF1
contribute to it. Therefore the anomalous migration of
ZEBRA might be due to posttranslational modification or
might result from its high proline content (28 of 209 amino
acids in the WZhet BZLF1).
Related work by others. Takada et al. have shown that the
BamHI Z fragment from B95-8 virus, when cloned down-
stream of powerful transcription signals in an avian retrovi-
rus long terminal repeat and introduced into Raji cells, will
activate transcription of the BamHI-H and -F regions of the
genome (30). Chevallier-Greco et al. confirmed and extended
this finding (4). Plasmids containing BZLF1 from HR-1
driven by the early simian virus 40 promoter and enhancer,
caused induction of expression of many transcripts in Raji
cells. Plasmids containing the BamHI-M and -S region,
which encodes a promiscuous transactivator (20, 33), were
unable to activate transcription in Raji cells. Similarly we
have not observed disruption of latency in either D98/HR-1
or X50-7 cells by the MB'het fragment, which contains the
coding region for this transactivator (20, 33). Using a re-
porter plasmid of the EBV DR promoter linked to chloram-
phenicol acetyltransferase, Chevallier-Greco found that the
BZLF1 function interacted with the BamHI-M and -S func-
tions in genome-negative BJAB cells. Neither Takada et al.
nor Chevallier-Greco et al. attempted to identify the protein
product responsible for disruption of latency, which we do in
our study. Studies of the latter group, however, which also
included a deletion mutant in BZLF1 and vectors lacking
enhancers or promoters, indicated that a protein was likely
to be responsible for transcription.
Seibl et al. (27) studied the products of the BamHI-Z
region by immunoprecipitation of proteins made by in vitro
translation of hybrid selected mRNAs and also those made
in vivo. They found variations in electrophoretic mobility of
proteins translated in vitro from B95-8 and HR-1 mRNAs
hybrid selected with plasmids containing BZLF1. However,
Seibl et al. were unable to distinguish the proteins made in
HR-1 cells from the defective virus as contrasted with those
encoded by the standard HR-1 virus. Our studies demon-
strate this reproducible difference in electrophoretic mobil-
ity, which is an extremely useful marker (Fig. 2, 3, and 4).
Seibl et al. did not conduct any functional studies which
related BamHI-Z products to the disruption of latency.
What is novel in our report is the correlation between
structural and functional studies. By using a variety of
mutants we were able to show that expression of the ZEBRA
proteins is needed for disruption of latency in D98/HR-1
cells.
Role of the rearranged sequences in WZhet. Our experi-
ments show that the sequences from BamHI-W do not play
a role in encoding the WZhet protein (Fig. 3). Furthermore
standard BamHI Z fragments, with no BamHI-W attached,
are able to activate expression of replicative proteins in
D98/HR-1 cells, albeit at a lower efficiency than WZhet (Fig.
5 and 6). Thus activation of latency does not absolutely
require BamHI W sequences. How does one reconcile this
with previous biologic experiments, which showed that
defective EBV is a potent agent able to induce EBV repli-
cation, whereas standard EBVs are considerably less effi-
cient at the process (22)?
As shown in this report, the ZEBRA protein encoded by
WZhet is more efficient at the induction of replication than
comparable proteins from standard viruses. Furthermore, in
the defective virus there is a large, 56-kbp palindrome which
contains two copies of the WZhet fragment (16). Thus
defective virus might also be more active by virtue of
increased copy number of the ZEBRA gene. The most likely
explanations, however, relate to differences in regulatory
signals.
Our experiments do not directly address questions about
the control of expression of ZEBRA. In the plasmid
pSV2neo, transcription is probably being driven by the
simian virus 40 promoter. One obvious potential role for the
sequences derived from BamHI W in the defective virus and
possibly in plasmids as well is to provide crucial cis-active
sequences which enhance the expression of ZEBRA. The
lower levels of induced viral replicative proteins seen (Fig. 6)
with mutants 81 and 80 which remove considerable portions
of the BamHI-W sequences is consistent with this hypothe-
sis. Recent experiments indicate that more ZEBRA protein
is expressed after transfection of Burkitt lymphoma cells
when the BZLF1 reading frame is linked to BamHI-W (C.
Rooney et al., submitted for publication). More must be
learned of the nature of the regulation ofZEBRA expression
in the standard and defective viruses. Clearly sequences
other than those from BamHI-W are upstream of the gene in
the standard genome and undoubtedly provide control sig-
nals (Fig. 1). Defective genomes may lack negative regula-
tory signals usually present in standard virus or may contain
novel positive-regulatory elements in the upstream region of
the ZEBRA gene. The deciphering of these signals will be
needed to learn why ZEBRA expression is usually sup-
pressed during EBV latency.
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